Associated Papers
Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes.
Soukupova J et al.
Plos One, 2018
29649263 (PubMed )
Supplement: pone.0195761.s003.xlsx › S3
Germline RAP80 mutations and susceptibility to breast cancer.
Akbari MR et al.
Breast Cancer Research and Treatment, 2009
Select a paper to view details